Filing Details
- Accession Number:
- 0001140361-13-019276
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-07 19:39:31
- Reporting Period:
- 2013-05-03
- Filing Date:
- 2013-05-07
- Accepted Time:
- 2013-05-07 19:39:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
707388 | Digirad Corp | DRAD | Electromedical & Electrotherapeutic Apparatus (3845) | 330145723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1386979 | M Charles Gillman | 13950 Stowe Drive Poway CA 92064 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-03 | 1,000 | $2.55 | 486,985 | No | 4 | P | Indirect | Shares held by Boston Avenue Capital LLC |
Common Stock | Acquisiton | 2013-05-06 | 5,000 | $2.45 | 491,985 | No | 4 | P | Indirect | Shares held by Boston Avenue Capital LLC |
Common Stock | Acquisiton | 2013-05-07 | 5,000 | $2.43 | 496,985 | No | 4 | P | Indirect | Shares held by Boston Avenue Capital LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Shares held by Boston Avenue Capital LLC |
No | 4 | P | Indirect | Shares held by Boston Avenue Capital LLC |
No | 4 | P | Indirect | Shares held by Boston Avenue Capital LLC |
Footnotes
- The purchases of shares reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by Boston Avenue Capital LLC on March 15, 2013.
- The reporting person is the Portfolio Manager for Boston Avenue Capital LLC ("Boston") and may be deemed to have the shared power to vote or direct the vote (and the shared power to dispose or direct the disposition) of the Issuer's Common Stock beneficially owned by Boston. The reporting person does not own any of the Issuer's Common Stock directly, and disclaims beneficial ownership of the Issuer's Common Stock beneficially owned by Boston.
- Represents the weighted average share price of an aggregate total of 5,000 shares purchased in the price range of $2.39 to $2.50 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Represents the weighted average share price of an aggregate total of 5,000 shares purchased in the price range of $2.40 to $2.50 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.